Loading institutional data...
Loading institutional data...
Insufficient data to determine institutional momentum.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
No trend data available for this metric.
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.4M 100.0% | $8.7M 100.0% | $4.1M 100.0% | $2.0M 100.0% | $1.6M 100.0% | $674K 100.0% | $717K 100.0% | $2.2M 100.0% |
| Cost of Revenue | $6.9M 60.5% | $5.9M 68.4% | $3.7M 90.9% | $1.8M 87.5% | $1.5M 99.5% | $965K 143.2% | $854K 119.1% | $1.7M 76.8% |
| Gross Profit | $4.5M 39.5% | $2.7M 31.6% | $374K 9.1% | $256K 12.5% | $8K 0.5% | -$291K -43.2% | -$137K -19.1% | $514K 23.2% |
| Research & Development | $2K 0.0% | $78K 0.9% | $103K 2.5% | $367K 17.9% | $31K 2.0% | — | — | — |
| Selling, General & Admin | $7.9M 68.8% | $6.2M 71.6% | $3.7M 91.7% | $3.2M 158.1% | $2.5M 164.2% | $2.0M 292.1% | $1.8M 249.2% | $2.4M 108.5% |
| Total Operating Expenses | $7.9M 68.8% | $6.3M 72.5% | $3.9M 94.2% | $3.6M 176.0% | $2.6M 166.2% | $2.0M 292.1% | $1.8M 249.2% | $2.4M 108.5% |
| Operating Income | -$3.4M -29.3% | -$3.6M -40.9% | -$3.5M -85.0% | -$3.3M -163.5% | -$2.6M -165.7% | -$2.3M -335.3% | -$1.9M -268.3% | -$1.9M -85.3% |
| Interest Expense | $34K 0.3% | $81K 0.9% | $15K 0.4% | $1.3M 65.2% | — | — | — | — |
| Other Income (Expense), net | $459K 4.0% | $91K 1.0% | $289K 7.1% | -$1.4M -68.3% | -$1.7M -112.2% | -$4K -0.6% | $1K 0.1% | — |
| Pretax Income | -$2.9M -25.3% | -$3.5M -39.9% | -$3.2M -78.0% | -$4.7M -231.7% | — | — | — | — |
| Income Tax Expense | — | — | — | $0 0.0% | $0 0.0% | $0 0.0% | $0 0.0% | — |
| Net Income | -$3.0M -26.3% | -$3.3M -37.8% | -$3.2M -77.2% | -$4.7M -231.7% | -$4.3M -277.9% | -$2.3M -335.9% | -$1.9M -268.2% | -$1.9M -85.3% |
| Per Share | ||||||||
| EPS (Basic) | $-0.38 | $-0.50 | $-0.56 | $-0.85 | $-1.45 | $-1.05 | $-0.14 | $-0.38 |
| EPS (Diluted) | $-0.38 | $-0.50 | $-0.56 | $-0.85 | $-1.45 | $-1.05 | $-0.14 | $-0.38 |
| Weighted Avg Shares (Basic) | 7.9M | 6.5M | 5.7M | 5.6M | 3.0M | 2.3M | 13.6M | 5.0M |
| Weighted Avg Shares (Diluted) | 7.9M | 6.5M | 5.7M | 5.6M | 3.0M | 2.3M | 13.6M | 5.0M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81 · book equity (no price)
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on -$1M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 8 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -59%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 8 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $317000 covers the $99000 due within a year 3.2× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~5.8% on $588000 of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
No current price collected.
Nothing notable to watch.
Where each multiple sits in its own 5-yr range
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 5-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
Profit and sales moved in opposite directions this year.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 76.8 | 119.1 | 143.2 | 99.5 | 87.5 | 90.9 | 68.4 | 60.5 |
| Gross Profit | 23.2 | -19.1 | -43.2 | 0.5 | 12.5 | 9.1 | 31.6 | 39.5 |
| R&D | — | — | — | 2.0 | 17.9 | 2.5 | 0.9 | 0.0 |
| SG&A | 108.5 | 249.2 | 292.1 | 164.2 | 158.1 | 91.7 | 71.6 | 68.8 |
| Operating Income | -85.3 | -268.3 | -335.3 | -165.7 | -163.5 | -85.0 | -40.9 | -29.3 |
| Income Tax | — | 0.0 | 0.0 | 0.0 | 0.0 | — | — | — |
| Net Income | -85.3 | -268.2 | -335.9 | -277.9 | -231.7 | -77.2 | -37.8 | -26.3 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on NXGL: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Top 18 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position